ArticlePreventive medicine reports2025
Beliefs and perceptions of genetic testing by clinical, demographic, and health characteristics: A U.S.-based study utilizing the health information national trends (HINTS) survey.
Article in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A cross-sectional study of genomic knowledge comfort, attitudes, ethical and educational perspectives on precision medicine among medical students in Ecuador.Journal of community genetics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Genetic testing and precision medicine enhance early detection and personalized treatment, potentially reducing morbidity and mortality. We examined how beliefs and perceptions of genetic testing and precision medicine differ by cancer history, gender, rural-urban status, physical activity, and obesity. Methods: We analyzed 3865 respondents from the Health Information National Trends Survey (HINTS) 5, Cycle 4, administered February 2020-June 2020. We assessed the associations between cancer history, demographic and health-related factors, with knowledge, beliefs, and perceptions of genetic testing and precision medicine. Adjusted Odds Ratios (AORs) and 95 % Confidence Intervals (CIs) were calculated. Results: Cancer survivors were more likely to have had genetic testing (AOR = 1.61; 95 % CI, 1.03-2.53) and to want to know if a genetic change increases cancer risk (AOR = 1.65; 95 % CI, 1.12-2.44). Men were more likely to report knowledge of precision medicine (AOR = 1.52; 95 % CI, 1.16-1.98) but less likely to believe genetic information is important for cancer prevention (AOR = 0.72; 95 % CI, 0.55-0.94). Those with less physical activity were less likely to report knowledge of precision medicine (AOR = 0.67; 95 % CI, 0.47-0.96) and genetic tests (AOR = 0.70; 95 % CI, 0.51-0.97). Individuals with obesity were more likely to believe genetic information is important for preventing (AOR = 1.36; 95 % CI, 1.06-1.75) and treating cancer (AOR = 1.27; 95 % CI, 1.02-1.59). Conclusion: Knowledge and beliefs about genetic testing and precision medicine vary by sociodemographic factors, in particular individuals with obesity are more likely to value genetic information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.